Title: Defining the Boundaries of Addiction: A Biological Perspective
1Defining the Boundaries of Addiction A
Biological Perspective
- Marc N. Potenza, M.D., Ph.D.
- Associate Professor of Psychiatry
- Director, Problem Gambling Clinic
- Director, Women and Addictions Core,
- Womens Health Research at Yale
- Director of Neuroimaging, VA VISN1
- MIRECC, West Haven VA Hospital
- Yale University School of Medicine
3rd Mind World Conference, May 4, 2007
2Overview
- Explore the Boundaries of Addiction - Are
Pathological Gambling (PG) and Other Impulse
Control Disorders (ICDs) Behavioral Addictions? - Examine the Relationship Between PG, Substance
Use Disorders (SUDs) and Other Mental Health
Disorders - Describe the Clinical Implications (Prevention,
Treatment) of Conceptualizing PG and Other ICDs
as Behavioral Addictions
3rd Mind World Conference, May 4, 2007
3What is Addiction?
- Addict (verb) - to devote or give (oneself)
habitually or compulsively from Latin addicere
- bound to or enslaved - Historical Shifts in Usage of Term
- Core Components of Addiction (Shaffer, 1999)
- - Continued Behavior Despite Adverse Consequences
- - Diminished or Lost Control / Compulsive
Engagement - - Craving or Urge State Component
3rd Mind World Conference, May 4, 2007
4Addiction As a Disorder of Motivation
- The Study of Obesity, Pathological Gambling, and
Other Motivated States Associated With Or Leading
to Compulsive Behavior Will Provide An
Opportunity to Learn About the Possible
Predispositions and Variations in the Reward
Circuit That Lead to Uncontrollable, Compulsive
Behavior, Independent of Direct Pharmacological
Activation of Brain Reward Circuits (NIDA,
Neuron, 2002)
3rd Mind World Conference, May 4, 2007
5What is Gambling?
- Gambling Is Placing Something of Value at Risk in
Hopes of Achieving Something of Greater Value
(Potenza et al, JAMA, 2001) - Perception Influenced by the Relative Amounts of
Risk and Reward - - Mutual Funds Vs. Day Trading
3rd Mind World Conference, May 4, 2007
6A Gambling Spectrum
- Non-gambling lt-gt Recreational Gambling lt-gt
Problem Gambling lt-gt Pathological Gambling - Recreational Gamblers Constitute a Majority
- Health Associations of Specific Levels of
Gambling Incompletely Understood - - Problem and Pathological Gambling Appear Most
Disruptive and Costly on a Per Capita Basis
3rd Mind World Conference, May 4, 2007
7Gambling Impact Behavior Study
- Problem and Pathological Gambling Are Associated
with High Rates of - - Divorce
- - Poor General Health
- - Mental Health Problems
- - Job Loss and Lost Wages
- - Bankruptcy
- - Arrest and Incarceration
- Problem Pathological Gambling Associated w/
Estimated Annual Societal Cost of 5 Billion
3rd Mind World Conference, May 4, 2007
8When Is Gambling a Problem?
- Pathological Gambling (PG) (Level 3)
- - Most Disordered Form of Gambling
- - DSM-IV-TR Disorder
- - Analogous to Substance Dependence
- Problem Gambling (Level 2)
- - Widely Used But Not a DSM-IV-TR Disorder
- - Analogous to Substance Abuse
3rd Mind World Conference, May 4, 2007
9Impulse Control Disorders As Behavioral
Addictions
- ICDs Not Elsewhere Classified
- - Pathological Gambling, Kleptomania, Pyromania,
Intermittent Explosive Disorder,
Trichotillomania, ICD NOS - ICDs Under Consideration
- - Compulsive Buying, Compulsive Sexual Behavior,
Compulsive Computer Use - ICDs Common in Hospitalized Psychiatric Pts
- - Among 204 Adult In-pts, 31 Had a Current ICD,
with lt2 Diagnosed Upon Admission (Grant et al,
Am J Psych, 2005) - Among 102 Patients Adolescent In-pts, 40 Had a
Current ICD, with lt1 Dxed Upon Admission
(Grant et al, J Clin Psych, in press)
3rd Mind World Conference, May 4, 2007
10Frequencies of ICDs in Adult Psychiatric
Inpatients
- Past-Year Lifetime
- Compulsive Buying 9.3 9.3
- Kleptomania 7.8 9.3
- Pathological Gambling 6.9 6.9
- Intermittent Explosive D/O 6.4 6.9
- Compulsive Sexual Behaviors 4.4 4.9
- Pyromania 3.4 5.9
- Trichotillomania 3.4 4.4
Grant et al, Am J Psychiatry, 2005
3rd Mind World Conference, May 4, 2007
11Psychiatric Diagnoses and ICDs
- No Differences in Admission Diagnoses for Mood,
Psychotic or Substance Use Disorders Between
Adult Pts with an ICD Vs. Those Without - Adults With an ICD More Likely (Trend) To Have
Multiple non-ICD Diagnoses (62.7 vs. 49.6
plt0.08) - Among Adolescents, ICD Presence was Associated
with Internalizing Disorders (78.0 vs. 55.7
plt0.02) and Prior Hospitalization (75.6 vs.
41.0 plt0.001) - Adolescents As Compared with Adults Showed
Different Patterns of ICDs, with Intermittent
Explosive Disorder Being Most Common (12.7 of
Sample)
Grant et al, AJP, 2005 JCP, in press
3rd Mind World Conference, May 4, 2007
12PG and Co-Occurring Disorders
- Rec Gam Vs Prob Gam
- Disorder Non Gam Vs Non Gam
- Major Depression 1.7 (1.1, 2.6) 3.3 (1.6, 6.8)
- Dysthymia 1.8 (1.0, 3.0) 2.1 (0.8, 5.7)
- Schizophrenia 0.6 (0.2, 1.8) 3.5 (1.3, 9.7)
- Phobias 1.2 (0.9, 1.7) 2.3 (1.2, 4.3)
- Somatization 1.7 (1.1, 2.8) 3.0 (1.6, 5.8)
- Antisocial PD 2.3 (1.6, 3.4) 6.1 (3.2, 11.6)
- Alcohol Use 3.9 (2.4, 6.3) 7.2 (2.3, 23.0)
- Alcohol Abuse/Dep 1.9 (1.3, 2.7) 3.3 (1.9,
5.6) - Nicotine Use 1.9 (1.6, 2.4) 2.6 (1.6, 4.4)
- Nicotine Dep 1.3 (1.0, 1.7) 2.1 (1.1, 3.8)
- NS Mania, Suicidality, OCD, Panic, GAD, Drug
Use, Drug Abuse/Dep - plt0.05
3rd Mind World Conference, May 4, 2007
Source Cunningham-Williams et al, 1998
13Relationship Between PG and SUDs
- High Rates of Co-Occurrence
- - Population and Clinical Samples
- Similar Clinical Courses
- - High Rates in Adolescence, Lower Rates in Older
Adults - - Telescoping Pattern in Women
- Similar Clinical Characteristics
- - Tolerance, Withdrawal, Repeated Attempts to Cut
Back or Quit - - Appetitive Urge or Craving States
- Similar Biologies
- - Genetic Contributions, Neural Circuits
- Similar Treatments
- - Self-Help, CBT, MI, Naltrexone and Nalmefene
3rd Mind World Conference, May 4, 2007
14Clinical Relevance of PG SUDs
- Individuals with Co-Occurring PG and SUDs
Experience More Severe Symptoms Than Those With
SUDs Alone (Kaplan Davis, 1997) - - Increased Rates of Admission for Detoxification
(gt Two-Fold Rate) - - Increased Rates of Admission for Psychiatric
Stabilization (gt 50 Increased Rate) - - More Suicidality (Federman et al, 1998)
3rd Mind World Conference, May 4, 2007
15Motivation in Addiction
- Motivated Behaviors Become Increasingly Limited
Over Time to Addiction-Related Actions - Neural System Abnormalities Underlying Motivated
Behaviors in Addiction Represent Important
Targets for Treatment - Motivational Neurocircuitry Differences Are
Likely Present At Specific Stages of Addiction - - Impulsive Decision-Making (Early ( Late)) vs.
Compulsive Engagement (Late)
3rd Mind World Conference, May 4, 2007
16Impulsivity as an Endophenotype
- Defining Impulsivity (Moeller et al, 2001)
- - A Predisposition Toward Rapid, Unplanned
Reactions to Internal or External Stimuli With
Diminished Regard to the Negative Consequences
of These Reactions to the Impulsive Individual or
to Others - Impulsivity Across Psychiatric Groups
- - ICDs, SUDs, Bipolar D/O, ADHD, ASPD, BPD,
Suicidality, SIB - Behavioral Measures of Impulsivity
- - Risk/Reward Assessment Decision-Making
Paradigms (Monetary Reward/Punishment,
Discounting, Gambling Tasks) - - Response Disinhibition/Attentional Paradigms
(Go/No-Go, Stroop)
3rd Mind World Conference, May 4, 2007
17Neural Systems and Addiction
- Mesocorticolimbic Dopamine System (Overactive
Motor) - - Ventral Tegmental Area, Nucleus Accumbens
- Frontal Serotonin Systems (Bad Brakes)
- - Frontal/Prefrontal Cortical Function
- Role for Neurotransmitter Systems Modulating DA,
5HT Function - - GABA, Glutamate, Opioids, ...
3rd Mind World Conference, May 4, 2007
18Roles for Neurotransmitters
- Neurotransmitter Role in Impulse Control
- Norepinephrine (NE) Arousal, Excitement
- Serotonin (5HT) Behavior Initiation/Cessation
- Dopamine (DA) Reward, Reinforcement
- Opioids Pleasure, Urges
Potenza and Hollander, 2002
3rd Mind World Conference, May 4, 2007
195-HT Impulse Control
- Low CSF 5-HIAA Associated w/ Impaired Impulse
Control (Potenza and Hollander, 2002) - Altered Biochemical and Behavioral Responses to
m-CPP (5HT1R and 5HT2R Partial Agonist) (DeCaria
et al, 1998) - Blunted 5HT Response in vmPFC in Impulsive
Aggression (Siever et al, 1999 New et al, 2002)
3rd Mind World Conference, May 4, 2007
20Impulsivity and Addiction
- Serotonergic Drugs (e.g., SSRIs) Have Shown Mixed
Results in the Tx of PG (Grant et al, 2003) - SSRI Tx May Be Particularly Effective for
Particular Groups of Individuals with PG - Individuals with PG and Co-Occurring Affective
Disorders (Grant and Potenza, 2006a)
3rd Mind World Conference, May 4, 2007
21Decision-Making, Reward Processing and Addiction
- Individuals with PG or SUDs Perform
Disadvantageously or Impulsively on Gambling
Tasks, and Performance Correlates with Real-Life
Measures (Petry et al, 2001 Bechara, 2003) - Individuals with PG or SUDs Discount Rewards
Rapidly Over Time (Bickel et al, 1999 Petry et
al, 2001) - Behavioral Measures of Reward Discounting Are
Associated with SUD Tx Outcome (Krishnan-Sarin et
al, 2007)
3rd Mind World Conference, May 4, 2007
22Reward Processing in Addiction
- Adults w/ AD vs Those w/o AD Show Less Activation
of NAc in Anticipation of Working for Monetary
Reward (Hommer et al, 2004) - Similar Findings in Adolescents and Adults FH
Vs. FH- for AD (Hommer et al, 2004) - Extends Across Addictions - Less Activation of
NAc in PG vs. Control During Monetary Wins vs.
Losses (Reuter et al, 2005)
3rd Mind World Conference, May 4, 2007
23Dopamine and ICDs in PD
- PG and Other ICDs Reported in Association with
Parkinsons Disease (Dodd et al, 2005) - Association Linked to Dopamine Agonist Treatment
(Weintraub Potenza, 2006) - Prior ICD and FH of EtOHism Associated with ICD
Presence in PD (Weintraub et al, 2006 Voon et
al, 2006) - Need to Identify Neurobiological Factors
Underlying Vulnerability to ICDs in PD
3rd Mind World Conference, May 4, 2007
24Genetics of PG, AD and AAB
- Shared Genetic Contributions to PG and AD
- - 12-20 of Genetic Variation in the Risk for PG
Accounted for by the Risk for AD (Slutske et al,
2000) - Shared Genetic Contributions to PG and AAB
- - 16-22 of Genetic Variation in the Risk for PG
Accounted for by the Risk for Anti-Social
Behaviors (Slutske et al, 2001) - Shared Risks Suggest Shared Genetic Contributions
to Risk for Impulsiveness
3rd Mind World Conference, May 4, 2007
25Pharmacological Treatment of AD
- FDA-Approved Drugs for AD (None for PG)
- - Disulfiram, Naltrexone, Acamprosate
- Naltrexone and Other Opioid Antagonists
Indirectly Modulate Dopamine Neurotransmission in
VTA-NAc Pathway - Might Naltrexone or Other Mu-Opioid Receptor
Antagonists Be Effective in Treating PG?
3rd Mind World Conference, May 4, 2007
26Opioid Antagonists
- High-Dose Naltrexone (Avg Dose 188 mg/day)
Effective in Targeting PG Sxs (Kim et al, 2001) - High Rates of Drop-Out LFT Abnormalities
- Greater Drug-Related Improvement in Subjects with
High Initial Gambling Urge Measures - - Similar to Naltrexone Cravings in AD
- Encouraging Findings with Opioid Antagonist
Nalmefene (Grant et al, 2006)
3rd Mind World Conference, May 4, 2007
27Association Between PG and MD in VET Sample
Variable OR (95 CI) p-value Alcohol
Abuse/Dependence 2.7 (1.5, 4.7) 0.001 Drug
Abuse/Dependence 1.9 (1.0, 3.3) 0.04 Antisocial
Personality D/O 2.5 (1.1, 5.5) 0.02 Generalized
Anxiety D/O 3.0 (1.3, 6.5) 0.007 Major
Depression 2.0 (1.1, 3.4) 0.02 NS Age,
Income, HS Education, College Education, Nicotine
Dependence, PTSD, Panic D/O Unadjusted OR for MD
4.1 (2.6-6.5) OR for MD Adjusting for
Sociodemographics 4.1 (2.6-6.5)
28Bivariate Biometric Model for PG MD
Potenza et al, 2005, Arch Gen Psychiatry
29Overall Conclusions
- PG and Other ICDs Are Common, Particularly Among
Psychiatric Pts - There Exist Multiple Shared Features Between ICDs
and SUDs - Characterizing Biological Mechanisms of ICDs Has
Implications for Categorizing Disorders and Tx
Development - Identification of PG and Other ICDs Critical For
Optimizing Clinical Care
3rd Mind World Conference, May 4, 2007
30The International Society for Research on
Impulsivity and Impulse Control Disorders (ISRI)
www.impulsivity. org (or contact
marc.potenza_at_yale.edu)